[Cholinesterase inhibitor therapy in long term care settings].

Source:http://linkedlifedata.com/resource/pubmed/id/16806591

Download in:

View as

General Info

Authors

Gilbert S, Wolmark Y, Kerneis S, Legrain S, Vantelon C, Kergoat MJ

Affiliation

Service de médecine gériatrique, centre hospitalo-universitaire Bichat-Claude-Bernard, 48, rue Henri-Huchard, 75877 Paris, France.

Abstract

Cholinesterase Inhibitors (ChEIs) have proven efficacy in outpatients with mild to moderate Alzheimer's Disease (AD). The benefits of maintaining this treatment once patients are institutionalised remain controversial. The aim of this study was to present current therapeutic strategies regarding ChEIs use in long-term care settings (LTC).

PMID
16806591

Publication types

English Abstract; Multicenter Study